Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Krebs Andreas (CIK 1438946) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Buy DFTX (1,629 shares), Buy DFTX (4,666 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Definium Therapeutics, Inc. (DFTX) | Director | Buy | 1,629 | $57,862 |
| 2026-06-15 | Definium Therapeutics, Inc. (DFTX) | Director | Buy | 4,666 | $0 |
Source: SEC Form 4 filings · as of 2026-09-18